Julie Margenthaler

Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Breast 45%
3. Mastectomy 42%
4. Segmental Mastectomy 34%
5. Neoplasms 24%
6. Carcinoma, Intraductal, Noninfiltrating 22%
7. Triple Negative Breast Neoplasms 18%
8. Mammaplasty 16%
9. Recurrence 16%
10. Sentinel Lymph Node 13%
11. African Americans 12%
12. Sentinel Lymph Node Biopsy 12%
13. Lymph Nodes 11%
14. Survival 11%
15. Drug Therapy 11%
16. Therapeutics 11%
17. Surgeons 11%
18. Radiotherapy 10%
19. Surgical Wound Infection 9%
20. Neoadjuvant Therapy 9%
21. Brachytherapy 9%
22. Skin 8%
23. Adjuvant Chemotherapy 8%
24. Neoplasm Metastasis 7%
25. Biopsy 7%
26. Anastrozole 7%
27. Nipples 7%
28. Estrogen Receptors 7%
29. Cancer Survivors 6%
30. Transplantation Tolerance 6%
31. Prophylactic Mastectomy 6%
32. Radiation 6%
33. Heart 6%
34. Propionibacterium acnes 6%
35. Guidelines 6%
36. Breast Diseases 6%
37. Randomized Controlled Trials 6%
38. Transgenic Mice 6%
39. Mortality 6%
40. Epidemiology 6%
41. T-Lymphocytes 6%
42. Isoantigens 6%
43. Tissue Expansion Devices 5%
44. Ultrasonography 5%
45. Lymph Node Excision 5%
46. Shared Decision Making 5%
47. Transplants 5%
48. Oncologists 5%
49. Incidence 5%
50. Axilla 5%